A. Balil

Time-to-progression in breast cancer: a stratification model for clinical trials.

A. Lluch, E. Alba, B. Munárriz, 2008, Breast.

Gemcitabine plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: final results of the phase III Spanish Breast Cancer Research Group (GEICAM) trial.

A. Ruíz, V. Guillem, N. Ribelles, 2007, The Lancet. Oncology.

Risk-adapted management for patients with clinical stage I seminoma: the Second Spanish Germ Cell Cancer Cooperative Group study.

J. Carles, B. Mellado, L. Paz-Ares, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adjuvant chemotherapy with sequential or concurrent anthracycline and docetaxel: Breast International Group 02-98 randomized trial.

R. Gelber, M. Buyse, A. Goldhirsch, 2008, Journal of the National Cancer Institute.

Epirubicin-cyclophosphamide adjuvant chemotherapy plus tamoxifen administered concurrently versus sequentially: randomized phase III trial in postmenopausal node-positive breast cancer patients. A GEICAM 9401 study.

A. Tres, E. Alba, M. Martín, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Multicenter randomized trial comparing sequential with concomitant administration of doxorubicin and docetaxel as first-line treatment of metastatic breast cancer: a Spanish Breast Cancer Research Group (GEICAM-9903) phase III study.

E. Alba, M. Ramos, Miguel Martín, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High-dose DICEP chemotherapy versus observation in metastatic breast cancer patients with monotopic disease responding to induction chemotherapy with paclitaxel plus epirubicin. Final results of a phase III GEICAM trial

E. Alba, Á. Rodríguez-Lescure, Miguel Martín, 2003, Revista de Oncología.

Is risk of central nervous system (CNS) relapse related to adjuvant taxane treatment in node-positive breast cancer? Results of the CNS substudy in the intergroup Phase III BIG 02-98 Trial.

M. Gnant, G. Viale, M. Piccart-Gebhart, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase III study of gemcitabine plus vinorelbine (VG) versus vinorelbine (V) in patients (pts) with metastatic breast cancer (MBC) previously treated with anthracyclines (A) and taxanes (T). Final results of GEICAM 2000-04 study.

E. Alba, L. Calvo, M. Muñoz, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.